Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months.

Risk-reducing surgeries provide benefits for young BRCA-mutation carriers

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or

December 11, 2024

Successful First Half of 2024 with Strategic Progress and Solid Financial Figures – Biotech Investments

Xlife Sciences AG / Key word(s): Half Year Results/Interim Report 19-Sep-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR

September 20, 2024

Bidco to acquire biopharmaceutical services company Ergomed

Ergomed is engaged in the outsourced pharma services sector. Credit: Lucas Vasques on Unsplash. Eden AcquisitionCo (Bidco) has signed an agreement to acquire British biopharmaceutical

September 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.